WO2024158285 - METHOD FOR PREVENTION OR TREATMENT OF CORONAVIRUS INFECTION
National phase entry is expected:
Publication Number
WO/2024/158285
Publication Date
02.08.2024
International Application No.
PCT/NL2024/050033
International Filing Date
25.01.2024
Title **
[English]
METHOD FOR PREVENTION OR TREATMENT OF CORONAVIRUS INFECTION
[French]
PROCÉDÉ DE PRÉVENTION OU DE TRAITEMENT D'UNE INFECTION À CORONAVIRUS
Applicants **
LEYDEN LABORATORIES B.V.
Emmy Noetherweg 2
2333 BK Leiden, NL
Inventors
GOUDSMIT, Jaap
c/o Emmy Noetherweg 2
2333 BK Leiden, NL
SHAW, Michael Alan
c/o Emmy Noetherweg 2
2333 BK Leiden, NL
Priority Data
23153350.6
25.01.2023
EP
23190707.2
09.08.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 2426 | |
| EPO | Filing, Examination | 11238 | |
| Japan | Filing | 589 | |
| South Korea | Filing | 607 | |
| USA | Filing, Examination | 6735 |
Total: 21595 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The invention is in the field of medical treatment and relates to a method for treating coronavirus infection. In particular, the present invention relates to methods for prophylactic and/or therapeutic treatment of coronavirus infection by means of the mucosal administration of antibodies against coronavirus.[French]
L'invention concerne le domaine du traitement médical et concerne un procédé de traitement d'une infection à coronavirus. En particulier, la présente invention concerne des procédés de traitement prophylactique et/ou thérapeutique d'une infection à coronavirus au moyen de l'administration par voie muqueuse d'anticorps contre le coronavirus.